Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Different types of white fat may play distinct roles in metabolic diseases

Excess white fat causes obesity, which in turn can drive diabetes and many other metabolic diseases that are growing at epidemic rates around the world.

5 May 2020

Cancer patients with COVID-19 more likely to die from the disease

People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.

2 May 2020

Research shows how the immune system reacts to hepatitis C viruses

If a virus penetrates a cell, the immune system reacts immediately and produces the signaling protein interferon.

24 Apr 2020

1.7 billion people at higher risk from COVID-19, study says

The COVID-19 pandemic affecting 185 countries and territories the world over has already claimed over 190,000 lives and sickened well over 2.7 million as of April 24, 2020. Research shows that most of these fatalities are in older people or those who have underlying medical conditions.

23 Apr 2020

Adults with spinal cord injury are at higher risk of developing mental health disorders

In a new study, published in Mayo Clinic Proceedings, researchers from Michigan Medicine find adults with spinal cord injury are at a higher risk of developing mental health disorders, including depression and anxiety, compared to adults without the condition.

22 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Study shows how interactions between microbiome and the immune system contribute to liver disease

A new study by researchers in the Quadram Institute has provided insights into how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease.

20 Apr 2020

Study: Early changes in microbiome development can impact health and disease later in life

A team of researchers at Children's Hospital of Philadelphia (CHOP) has characterized how the gut microbiome develops in the first hours of infancy, providing a critical baseline for how changes in this environment can impact health and disease later in life.

17 Apr 2020

Voluntary exercise could help prevent liver cancer, study shows

Liver cancer is the fourth most common cause of cancer death worldwide and is growing rapidly due to the "diabesity pandemic."

14 Apr 2020

USC scientists report wider benefits of well-known hangover drug

A well-known hangover drug not only helps soothe pounding headaches but also triggers profound changes that protect the liver, USC scientists report in new findings that could help prevent alcohol-related harm.

7 Apr 2020

USC researchers show wider benefits to drug used for hangovers

A well-known hangover drug not only helps soothe pounding headaches but also triggers profound changes that protect the liver.

7 Apr 2020

Researchers identify new biomarker to track the development of NAFLD

Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide.

7 Apr 2020

Young people weigh pain of job loss against risks of virus

Emilio Romero, 23, has mixed feelings about losing his job. It's a major financial setback, but with two previous hospitalizations for pneumonia, a restaurant was not the safest place for the recent college graduate as the COVID-19 pandemic mushroomed.

6 Apr 2020

Clinical trial to evaluate experimental COVID-19 drug is underway at Montefiore and Einstein

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.

5 Apr 2020

Patients with chronic liver disease need specific care during COVID-19

Currently, there are limited data on the impact of pre-existing liver disease and the course of SARS-CoV-2 infection, with many open questions.

2 Apr 2020

Study reveals how hormone leptin contributes to weight loss

Some call it baby fat. But recent research has shown that adults have it too--which is a good thing. Brown fat, the so-called good fat that can protect against obesity and associated health risks, like cardiovascular disease and diabetes, is located in small pockets throughout the body.

31 Mar 2020

Gastric bypass may be the best surgical option in patients with NAFLD

Bariatric surgery may be an effective treatment for non-alcoholic fatty liver disease (NAFLD), suggests a new study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in the Journal of the Endocrine Society.

31 Mar 2020

Neil Tween appointed as Chief Financial Officer of Owlstone Medical

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine today announces the appointment of Neil Tween as its new Chief Financial Officer.

From Owlstone Medical Ltd 31 Mar 2020

Factors causing childhood obesity differ for wealthier and poorer countries

Childhood obesity is not just a public health concern in western countries; it is rising across the world, particularly in poor and low-income countries.

26 Mar 2020

Overweight and obese people at higher risk of COVID-19

Since the coronavirus disease (COVID-19) first emerged in China, a series of studies have provided a better understanding of the virus and how it affects the human body. Evidence shows that vulnerable or high-risk populations include older adults, those who are immunocompromised, and those who have underlying medical conditions.

24 Mar 2020